Presentation and Long-Term Follow-up of Refractory Celiac Disease: Comparison of Type I With Type II
Georgia Malamut(Délégation Paris 5), Christophe Cellier(Assistance Publique – Hôpitaux de Paris), Pauline Afchain, Anne Lavergne‐Slove, Nadine Cerf–Bensussan(Université Paris Cité), Ludovic Trinquart(Tufts University), Nicole Brousse(Hôpital Necker-Enfants Malades), Aurélien Amiot(Université Paris-Est Créteil), Jacques Cosnes(Assistance Publique – Hôpitaux de Paris), Matthieu Allez(Inserm), Olivier Hermine(Centre National de la Recherche Scientifique), Yoram Bouhnik(Clinique Ambroise Paré), Elizabeth Macintyre(Inserm), Diane Damotte(Inserm), Thierry Lecomte(Université Paris Cité), Jean–Frédéric Colombel(Icahn School of Medicine at Mount Sinai), Isabelle Radford‐Weiss(Hôpital Necker-Enfants Malades), Virginie Verkarre(Université Paris Cité), Jean‐Charles Delchier(Assistance Publique – Hôpitaux de Paris), Bertrand Meresse(Centre Hospitalier Universitaire de Lille)
Cited by 378
Related Papers
<i>LMO2</i> -Associated Clonal T Cell Proliferation in Two Patients after Gene Therapy for SCID-X1
|Science|2003|3.5k
FOLFIRINOX or Gemcitabine as Adjuvant Therapy for Pancreatic Cancer
|New England Journal of Medicine|2018|2.9k
International Consensus Classification of Myeloid Neoplasms and Acute Leukemias: integrating morphologic, clinical, and genomic data
|Blood|2022|2.8k
Ustekinumab as Induction and Maintenance Therapy for Crohn’s Disease
|New England Journal of Medicine|2016|1.8k